WHO's updated policy for TB/HIV Collaboration

This important new policy emphasizes the need to maximise the delivery
of a range of medical and preventive interventions that are simplified, practical,
streamlined interventions that save lives:

Routine HIV testing for TB patients, people with symptoms of TB (TB suspects), and their sexual partners or family members; The use of a simple clinical algorithm for TB screening for PLHIV   that relies on the absence or presence of 4 symptoms: current cough, weight loss, fever and night sweats, to identify people living with HIV eligible for at least 6 months of isoniazid preventive therapy (IPT) or for further diagnostic investigations for TB. Provision of co-trimoxazole, a cost-effective medicine to prevent against lung or other infections for all TB patients who are infected with HIV; Starting all TB patients with HIV on ART as soon as possible (and within the first 2 weeks of starting anti-TB treatment) regardless of immune system measurements; HIV prevention in TB patients: Evidence-based methods to prevent the acquisition of HIV for TB patients, their families and communities Infection control in PLHIV From: Universal Health